| Updates on immunotherapy and immune landscape in renal clear cell carcinoma MC Kim, Z Jin, R Kolb, N Borcherding, JA Chatzkel, SM Falzarano, ... Cancers 13 (22), 5856, 2021 | 52 | 2021 |
| Simple and tunable surface coatings via polydopamine for modulating pharmacokinetics, cell uptake and biodistribution of polymeric nanoparticles J Liu, H Xu, X Tang, J Xu, Z Jin, H Li, S Wang, J Gou, X Jin RSC advances 7 (26), 15864-15876, 2017 | 37 | 2017 |
| Breast cancer stem cells: Signaling pathways, cellular interactions, and therapeutic implications L Wang, Z Jin, RP Master, CK Maharjan, ME Carelock, TBA Reccoppa, ... Cancers 14 (13), 3287, 2022 | 10 | 2022 |
| Targeting intracellular proteins with cell type-specific functions for cancer immunotherapy ME Carelock, RP Master, MC Kim, Z Jin, L Wang, CK Maharjan, N Hua, ... Life Medicine 2 (3), lnad019, 2023 | 3 | 2023 |
| Angiopoietin-like 4 suppress clear cell renal cell carcinoma via inhibition lysosomal acid lipase Z Jin, U De, T Tithi, J Kleberg, A Nataraj, E Jolley, B Davies, W Zhang, ... Cancer Research 84 (6_Supplement), 3177-3177, 2024 | | 2024 |
| Attenuating breast cancer metastasis with BCL-XL-targeting PROTACs ME Carelock, P Zhang, M Jiao, U De, Z Jin, RM Stump, SG Williams, ... Cancer Research 84 (6_Supplement), 4123-4123, 2024 | | 2024 |
| Proteolysis-targeting chimera against NR4A1 for cancer immunotherapy L Wang, Y Xiao, R Master, Y Luo, G Zheng, D Zhou, W Zhang The Journal of Immunology 210 (1_Supplement), 245.07-245.07, 2023 | | 2023 |
| Angiopoietin-like 4 as a potential therapeutic target for clear cell renal carcinoma Z Jin, U De, L Wang, J Kleberg, W Zhang, R Kolb Cancer Research 83 (7_Supplement), 571-571, 2023 | | 2023 |
